These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24780475)

  • 21. Functional profile of the isolated uremic nephron: potassium adaptation in the rabbit cortical collecting tubule.
    Fine LG; Yanagawa N; Schultze RG; Tuck M; Trizna W
    J Clin Invest; 1979 Oct; 64(4):1033-43. PubMed ID: 225350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.
    Shashar M; Belghasem ME; Matsuura S; Walker J; Richards S; Alousi F; Rijal K; Kolachalama VB; Balcells M; Odagi M; Nagasawa K; Henderson JM; Gautam A; Rushmore R; Francis J; Kirchhofer D; Kolandaivelu K; Sherr DH; Edelman ER; Ravid K; Chitalia VC
    Sci Transl Med; 2017 Nov; 9(417):. PubMed ID: 29167396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of protein-bound toxins, possibility for blood purification therapy.
    Neirynck N; Glorieux G; Schepers E; Pletinck A; Dhondt A; Vanholder R
    Blood Purif; 2013; 35 Suppl 1():45-50. PubMed ID: 23466378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired gut barrier in experimental chronic uremic rats.
    Magnusson M; Magnusson KE; Denneberg T
    Miner Electrolyte Metab; 1992; 18(2-5):288-92. PubMed ID: 1465077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derangement of acid-base balance in uremia and under hemodialysis.
    Messa P; Mioni G; Maio GD; Ferrando C; Lamperi D; Famularo A; Paoletti E; Cannella G
    J Nephrol; 2001; 14 Suppl 4():S12-21. PubMed ID: 11798141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trapping of urea and ammonia in the gut of uremic patients.
    Giordano C; Esposito R; Randazzo G; Pluvio M
    Adv Nephrol Necker Hosp; 1972; 2():251-62. PubMed ID: 4219692
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical studies and chronic kidney disease: what did we learn recently?
    Liabeuf S; Neirynck N; Drüeke TB; Vanholder R; Massy ZA
    Semin Nephrol; 2014 Mar; 34(2):164-79. PubMed ID: 24780471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal Barrier Function in Chronic Kidney Disease.
    Meijers B; Farré R; Dejongh S; Vicario M; Evenepoel P
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compositional characteristics of the gut microbiome in patients with uremia.
    Wu Z; Bian M; Zhang H; Wang M; Wang P; Shao Y; Shen L; Zhu G
    Indian J Pathol Microbiol; 2024 Jul; ():. PubMed ID: 39011618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of dietary fiber on chronic kidney disease： Base on the gut-kidney axis theory.
    Xie X; Dai S; Dai Y; Ning J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 45(2):193-197. PubMed ID: 32386047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy.
    Vanholder R; Boelaert J; Glorieux G; Eloot S
    Semin Dial; 2015; 28(2):114-24. PubMed ID: 25441338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of intact PTH by isolated perfused kidney and liver from uremic rats.
    Daugaard H; Egfjord M; Lewin E; Olgaard K
    Exp Nephrol; 1994; 2(4):240-8. PubMed ID: 8069660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on protein-bound uremic retention solutes.
    Vanholder R; Schepers E; Pletinck A; Neirynck N; Glorieux G
    J Ren Nutr; 2012 Jan; 22(1):90-4. PubMed ID: 22200422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nondialyzable uremic toxins.
    Piroddi M; Bartolini D; Ciffolilli S; Galli F
    Blood Purif; 2013; 35 Suppl 2():30-41. PubMed ID: 23676834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uremic encephalopathy.
    Rosner MH; Husain-Syed F; Reis T; Ronco C; Vanholder R
    Kidney Int; 2022 Feb; 101(2):227-241. PubMed ID: 34736971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should dialysis modalities be designed to remove specific uremic toxins?
    Baurmeister U; Vienken J; Ward RA
    Semin Dial; 2009; 22(4):454-7. PubMed ID: 19709001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conservative treatment of the uremic syndrome.
    Vanholder R; Argilés A; Beige J; Brunet P; Drüeke TB; Fliser D; Herget-Rosenthal S; Hörl WH; Jörres A; Perna A; Rodriguez-Portillo M; Spasovski G; Stegmayr B; Stenvinkel P; Wanner C; Wiecek A; Massy ZA
    Semin Dial; 2009; 22(4):449-53. PubMed ID: 19709000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.